Skeletal conditions such as developmental dysplasia of the hip (DDH), osteoporosis, and osteoarthritis affect millions worldwide, often causing chronic pain and disability. These disorders stem from ...

Rather than completely blocking all downstream signals, the peptide developed in this study focuses on inhibiting the activation of p38-MAPK. This is enough to downregulate the development of mature ...

A study conducted by researchers at Baylor College of Medicine and collaborating institutions reveals the molecular events leading to osteogenesis imperfecta type V, a form of brittle bone disease ...

Achondroplasia, also known as short-limb dwarfism, is associated with neurological symptoms and complications due to ...

Stem cells form the backbone of many cell-based therapies due to their unique properties, including the ability to self-renew and differentiate to many cell types. Multiple cell therapies deliver ...

Given the success of the previous collection, Bone Health and Development in Children and Adolescents, volume II, we are pleased to announce the launch of ...

A committee of the European Medicines Agency (EMA) declined to recommended Ipsen's (OTCPK:IPSEY) (OTCPK:IPSEF) drug palovarotene for approval in EU to treat a rare bone disorder. The EMA's Committee ...

NEW YORK -- Scientists have discovered a mutant gene that triggers the body to form a second, renegade skeleton, solving the mystery of a rare disease called FOP that imprisons children in bone for ...

NEW YORK - Scientists have discovered a mutant gene that triggers the body to form a second, renegade skeleton, solving the mystery of a rare disease called FOP that imprisons children in bone for ...